Intersect Capital buys $1,465,936 stake in HCP (HCP)

HCP (HCP) : Intersect Capital scooped up 800 additional shares in HCP during the most recent quarter end , the firm said in a disclosure report filed with the SEC on Aug 9, 2016. The investment management firm now holds a total of 38,017 shares of HCP which is valued at $1,465,936.HCP makes up approximately 0.86% of Intersect Capital’s portfolio.

Other Hedge Funds, Including , Victory Capital Management Inc reduced its stake in HCP by selling 142 shares or 2.33% in the most recent quarter. The Hedge Fund company now holds 5,961 shares of HCP which is valued at $229,856.Plante Moran Financial Advisors reduced its stake in HCP by selling 47 shares or 2.0% in the most recent quarter. The Hedge Fund company now holds 2,300 shares of HCP which is valued at $89,907. HCP makes up approx 0.06% of Plante Moran Financial Advisors’s portfolio. Commonwealth Financial Services added HCP to its portfolio by purchasing 2,000 company shares during the most recent quarter which is valued at $77,800. HCP makes up approx 0.09% of Commonwealth Financial Services’s portfolio. Barrett Asset Management sold out all of its stake in HCP during the most recent quarter. The investment firm sold 52 shares of HCP which is valued $1,994.

HCP opened for trading at $39.31 and hit $39.745 on the upside on Wednesday, eventually ending the session at $39.61, with a gain of 0.97% or 0.38 points. The heightened volatility saw the trading volume jump to 56,60,115 shares. Company has a market cap of $18,521 M.

On the company’s financial health, HCP reported $0.71 EPS for the quarter, beating the analyst consensus estimate by $ 0.01 according to the earnings call on Aug 9, 2016. Analyst had a consensus of $0.70. The company had revenue of $662.20 million for the quarter, compared to analysts expectations of $623.74 million. The company’s revenue was up 9.0% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.79 EPS.

Many Wall Street Analysts have commented on HCP. Company shares were Reiterated by Mizuho on Aug 10, 2016 to “Neutral”, Firm has raised the Price Target to $ 37 from a previous price target of $32 .HCP was Initiated by Raymond James to “Underperform” on Jul 26, 2016. HCP was Upgraded by Goldman to ” Neutral” on Jul 8, 2016.

HCP Inc. (HCP) is a real estate investment trust (REIT). The Company invests in real estate serving the healthcare industry in the United States. Its portfolio consists of investments in various healthcare segments: senior housing post-acute/skilled nursing life science medical office and hospital. Its portfolio includes owned portfolio unconsolidated joint ventures and developments and redevelopments. Its owned portfolio includes around 1040 properties under lease and 68 operating properties. It has interests in unconsolidated joint ventures representing around 88 properties in its senior housing life science and medical office segments. It has assets under development redevelopment and land held for future development in life science and medical office segments. The properties owned by it in medical office and senior housing segments which are under development or redevelopment include Pacific Corporate Park Memorial Hermann Sky Ridge Bayfront Folsom and Deer Park.

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *